Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia
Abstract
1. A French multigeneration pedigree with hyperlipoproteinaemia was investigated for the transmission of the rare apolipoprotein E1(Gly127 → Asp, Arg158 → Cys) variant. The proband, a 46-year-old male carrying the rare apoE1 variant, presented a severe type III hyperlipoproteinaemia like his three brothers and his sister. 2. ApoE phenotyping and genotyping showed a discrepancy in the second allele carried by the proband's wife and two of her children, thus suggesting another apoE gene mutation. Cloning and sequencing of the entire exon 4 demonstrated a point mutation at codon 251, leading to an apoE3(Cys112 → Arg, Arg251 → Gly) allele. The proband's wife was normolipaemic and heterozygous for this rare isoform and the common apoE3 protein. The rare apoE3(Cys112 → Arg, Arg251 → Gly) allele has been transmitted to her two daughters. The first, aged 19, was normolipaemic and heterozygous for this allele and the common apoE2 allele. The second, carrying both the rare isoforms apoE1(Gly127 → Asp, Arg158 → Cys) and apoE3(Cys112 → Arg, Arg251 → Gly), presented a hypertriglyceridaemia at the age of 10. 3. The exploration of apoE status associated with plasma lipid levels and lipoprotein profiles in this three-generation pedigree made it possible to describe a compound heterozygote for two mutated alleles, one mutation being located in the N-terminal domain of the apoE protein and the other arising in the C-terminal domain.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Based on previous research, the ε2ε1 genotype is considered likely pathogenic for FD.
“Based on previous research data [32,33,34,35,36], we considered the ε2ε1 genotype as likely pathogenic for FD.”
From Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia (2024) · cites this paper as [34]
Three carriers of the rare p.Gly145Asp variant had the ε2ε2 genotype, forming the rare ε2ε1 genotype.
“In our study, three carriers of the rare p.Gly145Asp variant had the ε2ε2 (homozygous for the common p.Arg176Cys variant), forming the rare ε2ε1 genotype [32,33,34,35,36].”
From Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia (2024) · cites this paper as [34]
Cited by
Sorted by citations
APOE gene variants in primary dyslipidemia
Khalil, Y. A., Rabès, J.-P., Boileau, C., & Varret, M. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.007 · Cited by 170 · see citing works
Blokhina, A. V., Ershova, A. I., Kiseleva, A. V., Sotnikova, E. A., Zharikova, A. A., Zaicenoka, M., Vyatkin, Y. V., Ramensky, V. E., Kutsenko, V. A., Garbuzova, E. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312651 · Cited by 8 · see citing works
- Authors
- Richard, P., Beucler, I., De Zulueta, M. P., Biteau, N., De Gennes, J.-L., & Iron, A.
- Affiliations
- Université de Bordeaux (FR)
- Pitié-Salpêtrière Hospital (FR)
- UPR-ES Pathologie Moléculaire et Thérapie Génique, Département Biochimie Médicale et Biologie Moléculaire, Université Bordeaux 2, 33076 Bordeaux Cedex, France
- † Clinique des Maladies Métaboliques, CHU Pitié-Salpétrière, 75651 Paris Cedex 13, France
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1997-07-01
- Volume
- 93
- Issue
- 1
- Pages
- 89-95
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2408814527
- Cited by
- 10
- References
- 0
- Citations by year
- 2024: 1 · 2022: 4 · 2021: 2 · 2020: 1 · 2016: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- apolipoprotein E, compound heterozygosity, hyperlipoproteinemia, hypertriglyceridemia, N-terminal domain, C-terminal domain, plasma lipids, lipoprotein profile
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alleles, Apolipoproteins E, Child, Electrophoresis, Female, Genetic Markers, Genotype, Heterozygote, Humans, Hyperlipoproteinemia Type III, Isomerism, Male, Middle Aged, Pedigree, Phenotype, Polymorphism, Restriction Fragment Length, Point Mutation, Apolipoprotein E3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review